Brain machine interface for Parkison's disease

Parkinson's disease, a prevalent neurodegenerative disorder second only to Alzheimer's disease, is characterized by motor symptoms such as tremors, rigidity, and impaired balance due to the progressive loss of dopamine-producing neurons in the substantia nigra. Traditional treatment methods, including oral and intravenous dopamine, are ineffective due to the blood-brain barrier, while long-term use of levodopa presents significant drawbacks. Advances in microelectronics have introduced neural probes as promising tools for both the study and treatment of Parkinson's disease. This review examines the capabilities of neural probes to monitor neural activity, detect real-time dopamine concentrations, and facilitate localized intracerebral dopamine delivery. We discuss the design challenges and solutions for creating minimally invasive, long-term stable neural probes, emphasizing the importance of flexible substrates, biocompatible coatings, and integrated microfluidic channels. The proposed multimodal neural probe aims to improve our understanding of the relationship between dopamine and Parkinson's disease, offering new avenues for diagnosis and treatment. This work underscores the potential of neural probes to revolutionize Parkinson's disease research and therapy, contributing to the broader field of neuroengineering and neurotherapeutics.